Gilead Sciences, Inc. (GILD) - 재무정보
| 연도 | 매출 | 영업이익 | EPS | 부채비율(%) | PER |
|---|---|---|---|---|---|
| FY2021 | $27.30B | $10.86B | $4.93 | 222.6% | 12.69 |
| FY2022 | $27.28B | $10.97B | $3.64 | 197.8% | 21.28 |
| FY2023 | $27.12B | $8.81B | $4.50 | 173.1% | 17.66 |
| FY2024 | $28.75B | $10.51B | $0.38 | 206.5% | 235.56 |
| 연도 | 매출 | 영업이익 | EPS | 부채비율(%) | PER |
|---|---|---|---|---|---|
| FY2021 | $27.30B | $10.86B | $4.93 | 222.6% | 12.69 |
| FY2022 | $27.28B | $10.97B | $3.64 | 197.8% | 21.28 |
| FY2023 | $27.12B | $8.81B | $4.50 | 173.1% | 17.66 |
| FY2024 | $28.75B | $10.51B | $0.38 | 206.5% | 235.56 |